Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 465
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 131
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Musculoskeletal Disorders Drugs 93
Clinical Trials 90
Pharmaceuticals 89
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,377 Results (Page 55 of 119)
- Relevance
  Sort by

TKI for Chronic Myeloid Leukemia Market - Global Forecast 2026-2032

 Report
January 2026
189 Pages
Global

From

€3136EUR$3,545USD£2,721GBP

€3485EUR$3,939USD£3,023GBP

Treatment of Blastic-Phase CML Market - Global Forecast 2026-2032

 Report
January 2026
185 Pages
Global

From

€3136EUR$3,545USD£2,721GBP

€3485EUR$3,939USD£3,023GBP

Ibrutinib Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3972EUR$4,490USD£3,446GBP

Multiple Myeloma Therapeutics Market - Global Forecast 2026-2032

 Report
January 2026
193 Pages
Global

From

€3136EUR$3,545USD£2,721GBP

€3485EUR$3,939USD£3,023GBP

Chronic Lymphocytic Leukemia Therapeutics Market - Global Forecast 2026-2032

 Report
January 2026
189 Pages
Global

From

€3136EUR$3,545USD£2,721GBP

€3485EUR$3,939USD£3,023GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Chronic Myelogenous Leukemia Therapeutics Market - Global Forecast 2026-2032

 Report
January 2026
186 Pages
Global

From

€3136EUR$3,545USD£2,721GBP

€3485EUR$3,939USD£3,023GBP

Multiple Myeloma Drug Market - Global Forecast 2026-2032

 Report
January 2026
192 Pages
Global

From

€3136EUR$3,545USD£2,721GBP

€3485EUR$3,939USD£3,023GBP

Acute Lymphoblastic Leukemia Treatment Market - Global Forecast 2026-2032

 Report
January 2026
192 Pages
Global

From

€3136EUR$3,545USD£2,721GBP

€3485EUR$3,939USD£3,023GBP

Hairy Cell Leukemia Therapeutics Market - Global Forecast 2026-2032

 Report
January 2026
197 Pages
Global

From

€3136EUR$3,545USD£2,721GBP

€3485EUR$3,939USD£3,023GBP

Myelodysplastic Syndrome Market - Global Forecast 2026-2032

 Report
January 2026
184 Pages
Global

From

€3136EUR$3,545USD£2,721GBP

€3485EUR$3,939USD£3,023GBP

Acute Myeloid Leukemia Therapeutics Market - Global Forecast 2026-2032

 Report
January 2026
198 Pages
Global

From

€3136EUR$3,545USD£2,721GBP

€3485EUR$3,939USD£3,023GBP

Chronic Cough Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3972EUR$4,490USD£3,446GBP

Pulmonary Embolism Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
October 2022
411 Pages
Global

From

€2212EUR$2,500USD£1,919GBP

Non-Hodgkin Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

 Report
November 2025
187 Pages
Global

From

€3981EUR$4,500USD£3,454GBP

Multiple Sclerosis (MS) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030

 Drug Pipelines
April 2023
117 Pages
Global

From

€13267EUR$14,995USD£11,509GBP

Sexually Transmitted Diseases (STD) Treatment Market 2025-2029

 Report
July 2025
220 Pages
Global

From

€2212EUR$2,500USD£1,919GBP

Non-Hodgkin Lymphoma (NHL) Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
November 2025
180 Pages
Global

From

€3981EUR$4,500USD£3,454GBP

Treatment for Accelerated-Phase CML Market - Global Forecast 2025-2030

 Report
August 2025
184 Pages
Global

From

€3136EUR$3,545USD£2,721GBP

€3485EUR$3,939USD£3,023GBP

TIL Therapies Market Industry Trends and Global Forecasts to 2035, by Target Indication, Key Players and Key Geographical Regions

 Report
February 2025
315 Pages
Global

From

€4246EUR$4,799USD£3,683GBP

Alexipharmic Drugs Market by Application, by Route of Administration, by End-Users, and By Region

 Report
March 2024
200 Pages
Global

From

€3672EUR$4,150USD£3,185GBP

2,377 Results (Page 55 of 119)
- 1
- 53
- 54
- 55
- 56
- 57

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.